Public Reporting

ACO Name & Location

Emergent ACO, LLC
2323 N. John B Dennis Hwy
Kingsport, TN 37660

ACO Primary Contact

Primary Contact Name: Scott R. Fowler, J.D., M.D.
Primary Contact Phone: 423-857-2091
Primary Contact Email: scott.fowler@myhmg.com

Organizational Information
ACO Participants:
ACO Participants ACO Participant
in Joint Venture
(Enter Y or N)
Holston Medical Group, PC Y
HealthStar Physicians, PC Y
Goshen Medical Center Incorporated Y
RDMG Associates, PA Y
Optimed Hospitalists Y
Iredell Physician Network, LLC Y
Gastroenterology Associates Y
RTP Healthy Wellness, PLLC Y
Dillon Family Medicine, P.A. Y
Upper Cumberland Rural Health PLLC Y
Central Nebraska Medical Clinic, PC Y
Bristol Surgical Associates PC Y
Columbus Medical Center, PC Y
Express Med of Tennessee LLC Y
Fillmore County Medical Center, PC Y
Fort Norfolk Plaza Medical Associates, LLC Y
Cary Skin Center, PA Y
Family Medicine Health Care PLLC Y
Internal Medicine and Pediatric Associates of Bristol Y
Carolina Family Healthcare, PA Y
East Tennessee Spine & Orthopaedic Specialists, PC Y
Falls City Family Practice, PC Y
LifeCare Family Medicine of Bellevue, PC Y
Bloomfield Medical Clinic PC Y
Family Medical Center PC Y
Horner Montgomery And Breckenridge Y
Integrated Health Concepts, LLC Y
Meadowview ENT Specialist Y
Primary Care Specialists, Inc Y
Professional Health Care, Inc. Y
Rogersville Vision Center, PLLC Y
The Reeves Eye Institute Y
Charles City Medical Group Inc Y
Divine Health Care LLC Y
Old Hampton Family Medical Associates PC Y
Virginia Family Practice PC Y
Dr-AL Family and Urgent Care, PLC Y
East Coast Physicians PC Y
Adult And Pediatric Medical Associates, PC Y
Cardiac Connections Home Health Care Nursing Services Corp Y
Central Virginia Family Medicine, P.C. Y
Horace Jackson, M.D. Y
John Gehman Y
Lei S. Charlton, MD, PC Y
Leon J. Brown, Jr., MD, PC Y
Lifestyle And Wellness Center LLC Y
Lindley Smith Y
Md Wellness And Health Center Y
Newport Internal Medicine, PC Y
Peoples Pharmacy LLC Y
ACO Governing Body:
Member Member’s Voting
Power – Expressed as
a Percentage or Number		 Membership Type ACO Participant
Legal Business
Name/DBA, if
Applicable
Last Name First Name Title/Position
Fowler, J.D., M.D. Scott Director 6.6666% ACO Participant Representative Holston Medical Group, PC
Hager, M.D. Shelton Director 6.6666% ACO Participant Representative Holston Medical Group, PC
Moye David Director 6.6666% ACO Participant Representative RDMG Associates, PA
Wenzlik, M.D. Adam Director 6.6666% ACO Participant Representative RDMG Associates, PA
Delay, M.D. Eric Director 6.6666% ACO Participant Representative HealthStar Physicians, PC
McNabney, M.D. David Director 6.6666% ACO Participant Representative HealthStar Physicians, PC
Imperial, M.D. Eva Director 6.6666% ACO Participant Representative Iredell Physician Network, LLC
Ajjan, M.D. Mahdi Director 6.6666% ACO Participant Representative Optimed Hospitalists
Minnick, M.D. David Director 6.6666% ACO Participant Representative Central Nebraska Medical Clinic, PC
Tramp, M.D. Allan Director 6.6666% ACO Participant Representative Falls City Family Practice, PC
Joseph, M.D. Lerla Director 6.6666% ACO Participant Representative Charles City Medical
Fitzgibbon, M.D. Timothy Director 6.6666% ACO Participant Representative Dillon Family Medicine
Montgomery, M.D. Charles Director 6.6666% ACO Participant Representative Horner Montgomery & Breckenridge
Snodgrass Irma Director 6.6666% Medicare Beneficiary Medicare Beneficiary Representative
Hewitt Craig Director 6.6666% Community Stakeholder OnePartner Health Solutions, LLC
Key ACO clinical and administrative leadership:
ACO Executive: Scott R. Fowler, J.D., M.D.
Medical Director: Shelton L. Hager, M.D.
Compliance Officer: Thomas V. Thomas, M.D.
Quality Assurance/Improvement Officer: Samantha Sizemore, COO
Associated committees and committee leadership:
Committee Name Committee Leader Name and Position
Clinical Transformation Committee Shelton Hager, MD – Committee Chair
Operations, Quality, Clinical Process, and Population Health Improvement Committee Samantha Sizemore, COO – Committee Chair
Beneficiary Engagement Committee Danielle Cannon, Marketing & Communications Manager, Committee Chair
Communications & Marketing Committee Danielle Cannon, Marketing & Communication Manager – Committee Chair
Technology & Data Analytics Committee Wesley Combs, CIO – Committee Chair
Contracting & Finance Committee Craig Hewitt, CFO – Committee Chair
Compliance Committee Thomas V. Thomas, MD – Committee Chair
Types of ACO Participants, or Combinations of Participants, that Formed the ACO:
  • Networks of individual practices of ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
  • Second Agreement Period
    • Performance Year 2020 – January 1, 2020 – December 31, 2020, $ 8,679,219.81
  • First Agreement Period
    • Performance Year 2019 A – July 1, 2019 – December 31, 2019, $3,289,869.51

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings/losses amount reported for Performance Year 2019, therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

Shared Savings Distribution
  • Second Agreement Period
    • Performance Year 2020 – January 1, 2020 – December 31, 2020
      • Proportion invested in infrastructure: 0%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 80%
  • First Agreement Period
    • Performance Year 2019A – July 1, 2019 – December 31, 2021
      • Proportion invested in infrastructure: 0%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 100%

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings/losses amount reported for Performance Year 2019, therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

Quality Performance Results
2020 Quality Performance Results:
ACO Quality
Measure Number		 Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information N/A N/A
ACO-2 CAHPS: How Well Your Providers Communicate N/A N/A
ACO-3 CAHPS: Patients’ Rating of Provider N/A N/A
ACO-4 CAHPS: Access to Specialists N/A N/A
ACO-5 CAHPS: Health Promotion and Education N/A N/A
ACO-6 CAHPS: Shared Decision Making N/A N/A
ACO-7 CAHPS: Health Status/Functional Status N/A N/A
ACO-34 CAHPS: Stewardship of Patient Resources N/A N/A
ACO-45 CAHPS: Courteous and Helpful Office Staff N/A N/A
ACO-46 CAHPS: Care Coordination N/A N/A
ACO-38 [1,2] All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 52.56 49.5
ACO-43 [3] Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) 2.02 0.95
ACO-13 Falls: Screening for Future Fall Risk 98.32 84.97
ACO-14 Preventive Care and Screening: Influenza Immunization 90.75 76.03
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 78.85 81.67
ACO-18 Preventive Care and Screening: Screening for Depression and Follow-up Plan 77.53 71.46
ACO-19 Colorectal Cancer Screening 87.18 72.59
ACO-20 Breast Cancer Screening 88.78 74.05
ACO-40 Depression Remission at Twelve Months N/A N/A
ACO-27 Diabetes: Hemoglobin A1c Poor Control (>9%) 13.22 13.88
ACO-28 Controlling High Blood Pressure 76.28 75.04

Please note, the ACO-40 Depression Readmission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk Standardizd, All Condition Readmission and ACO -38 Risk Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease in 2019 (COVID-19) public health emergency (PHE) on these measures.

Please also note that per CMS policy, you should not publicly share or report cell sizes <11 or any combination of information that would allow cell sizes of <11 to be calculated.

Payment Rule Waivers
  • Waiver for Payment for Telehealth Services:
    • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.
  • Summary of Arrangement Conducted Under the Medicare ACO Participation Waiver



Last updated on August 31, 2021